eISSN 2508-3589
pISSN 2508-1926

Table. 1.

Table. 1.

Baseline characteristics of the both groups

Charecteristic BVZ group (n = 15) DEX group (n = 13) p-value
Age (years) 59.80 ± 9.09 66.40 ± 7.93 0.106*
Sex (M:F) 9:6 9:4 0.801
Initial CMT 424.20 ± 103.25 435.60 ± 71.71 0.405*
Initial BCVA (logMAR) 0.38 ± 0.17 0.41 ± 0.24 0.572*
Diabetic mellitus duration (months) 132.80 ± 58.51 91.20 ± 48.39 0.055*
Hypertension 3 (20.0) 4 (30.7) 0.378
Pseudophakic eye 2 (13.3) 0 0.500

Values are presented as mean ± standard deviation or number (%). BVZ = intravitreal bevacizumab injection; DEX = intravitreal dexamethasone implant injection; M:F = male:female; CMT = central macular thickness; BCVA = best corrected visual acuity; logMAR = logarithm of the minimum angle of resolution.

Mann-Whitney U tests;

Fisher's exact test.

J Retin 2019;4:84-92 https://doi.org/10.21561/jor.2019.4.2.84
© 2019 J Retin